Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
GNVR
)
0.6150
UNCHANGED
Last Price
Updated: 3:32 PM EST, Feb 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.6150
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.6150
Today's Range
0.6150 - 0.6150
52wk Range
0.0140 - 2.000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026
Today 8:00 EST
Via
ACCESS Newswire
Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions
March 04, 2026
Company’s proprietary peptide platform expands beyond agriculture into human recovery, performance, and wellness
From
Genvor Inc
Via
GlobeNewswire
Performance
YTD
-52.7%
-52.7%
1 Month
-18.0%
-18.0%
3 Month
-61.6%
-61.6%
6 Month
-38.5%
-38.5%
1 Year
+153650.0%
+153650.0%
More News
Read More
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
February 11, 2026
From
Genvor Inc
Via
GlobeNewswire
Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco
February 27, 2024
Via
ACCESSWIRE
Genvor to Attend BioSolutions Conference & Expo in Visalia, California
February 20, 2024
Via
ACCESSWIRE
Genvor Provides Fiscal First Quarter 2024 Corporate Update
February 15, 2024
Via
ACCESSWIRE
Genvor Appoints Veteran Agribusiness Leader Chad Pawlak as Chief Executive Officer
January 17, 2024
Via
ACCESSWIRE
Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization
January 28, 2026
From
Genvor Inc
Via
GlobeNewswire
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
January 20, 2026
From
Genvor Inc
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
December 09, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Genvor to Present at the Life Sciences Virtual Investor Forum December 11th
December 04, 2025
From
Virtual Investor Conferences; Genvor, Inc.
Via
GlobeNewswire
Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies
December 02, 2025
From
Genvor Inc
Via
GlobeNewswire
Genvor Inc. Partners With B2i Digital as Featured Company to Expand Investor Awareness
November 26, 2025
Via
NewMediaWire
Topics
Intellectual Property
Genvor Inc. Partners With B2i Digital as Featured Company to Expand Investor Awareness
November 26, 2025
Via
TheNewswire.com
Topics
Intellectual Property
Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide
November 12, 2025
From
Genvor Inc
Via
GlobeNewswire
Genvor Restores Trading Status and Expands Global Collaborative Research Network
October 09, 2025
From
Genvor Inc
Via
GlobeNewswire
Genvor to Unveil Latest Research on Patented Peptides for Aflatoxin Resistance in Corn at BioAgTech World Congress
April 22, 2024
Via
ACCESSWIRE
Genvor to Participate in BioAgTech World Congress in Raleigh, North Carolina
April 02, 2024
Via
ACCESSWIRE
Frequently Asked Questions
Is GNVR publicly traded?
Yes, GNVR is publicly traded.
What exchange does GNVR trade on?
GNVR trades on the OTC Traded
What is the ticker symbol for GNVR?
The ticker symbol for GNVR is GNVR on the OTC Traded
What is the current price of GNVR?
The current price of GNVR is 0.6150
When was GNVR last traded?
The last trade of GNVR was at 02/26/26 03:32 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.